FUJI PHARMA CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,507 JPY | +2.17% |
|
+0.74% | -13.34% |
| 2023 | Mithra Pharmaceuticals' License Partner Files for Estelle's Marketing Approval in Japan; Shares Jump | MT |
| 2023 | Alvotech Partner Secures Marketing Approval for Stelara Biosimilar AVT04 in Japan | MT |
Evolution of the average Target Price on Fuji Pharma Co., Ltd.
Price target over the last 5 years
History of analyst recommendation changes
298bd02bb8c68704c4b5af7.1lVpWSm0J_Nc4F0ozMuxovxJMI9voQ8ANrm7UzmEg74.nTYhNkT-SIlsmCtGhvzc2KMgfOIExkFUR_DWDHDq5d2EBCsNff93nwqEKg~47c908c972928f38613e3c2bb67f3b6b
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1,507
JPY
Average target price
2,057
JPY
Spread / Average Target
+36.47%
High Price Target
2,170
JPY
Spread / Highest target
+43.99%
Low Price Target
2,000
JPY
Spread / Lowest Target
+32.71%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
- Stock Market
- Equities
- 4554 Stock
- Consensus Fuji Pharma Co., Ltd.
